Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zankovich

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trialH M Kvasnicka, J Thiele, A Schmitt-Graeff, et al.
Blut|February 1, 1988
Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alphaR Hehlmann, B Anger, D Messerer, et al.
British Journal of Haematology|March 22, 2001
Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patientsH M Kvasnicka, J Thiele, A Schmitt-Graeff, et al.
American Journal of Clinical Pathology|July 8, 2000
Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic featuresJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Onkologie|February 1, 1988
[Chemotherapy of chronic myelocytic leukemia. Status of the German Multicenter Study on busulfan versus hydroxyurea versus alpha interferon, October 1897]R Hehlmann, B Anger, D Messerer, et al.
Annals of Hematology|June 1, 1993
Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrowJ Thiele, H M Kvasnicka, B R Titius, et al.
Leukemia & Lymphoma|February 16, 2000
Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patientsJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trialH M Kvasnicka, J Thiele, A Schmitt-Graeff, et al.
Blut|February 1, 1988
Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alphaR Hehlmann, B Anger, D Messerer, et al.
British Journal of Haematology|March 22, 2001
Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patientsH M Kvasnicka, J Thiele, A Schmitt-Graeff, et al.
American Journal of Clinical Pathology|July 8, 2000
Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic featuresJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Onkologie|February 1, 1988
[Chemotherapy of chronic myelocytic leukemia. Status of the German Multicenter Study on busulfan versus hydroxyurea versus alpha interferon, October 1897]R Hehlmann, B Anger, D Messerer, et al.
Annals of Hematology|June 1, 1993
Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrowJ Thiele, H M Kvasnicka, B R Titius, et al.
Leukemia & Lymphoma|February 16, 2000
Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patientsJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Pageof 5